Two BIOCAD products, Acellbia (INN: rituximab) and Herticad (INN: trastuzumab), received the first European registration certificate in Bosnia and Herzegovina.
More
Biotechnological company BIOCAD has announced the research in order to create an mRNA vaccine against SARS-COV-2 (coronavirus). Development will be
More